LCID — Lucid Income Statement
0.000.00%
Last trade - 00:00
- $5.66bn
- $3.95bn
- $595.27m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.59 | 3.98 | 27.1 | 608 | 595 |
Cost of Revenue | |||||
Gross Profit | 0.664 | 0.906 | -128 | -1,038 | -1,341 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 263 | 603 | 1,560 | 3,202 | 3,695 |
Operating Profit | -258 | -599 | -1,533 | -2,594 | -3,100 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -277 | -720 | -2,580 | -1,304 | -2,827 |
Provision for Income Taxes | |||||
Net Income After Taxes | -277 | -719 | -2,580 | -1,304 | -2,828 |
Net Income Before Extraordinary Items | |||||
Net Income | -277 | -719 | -2,580 | -1,304 | -2,828 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -269 | -706 | -4,747 | -2,559 | -2,828 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.166 | -0.436 | -2.93 | -1.52 | -1.35 |